Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 2/20 | 0.37 |
| ▸ | FGF2 | P09038 | 2/20 | 0.37 |
| ▸ | VEGFA | P15692 | 2/20 | 0.37 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.34 |
| ▸ | CDC25B | P30305 | 5/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472853 | 0.90 | NT5E (0.44) | FGF1FGF2VEGFAHPSENT5E | |
| SCHEMBL2629589 | 0.90 | LGALS8 (0.43) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL472845 | 0.90 | LGALS8 (0.43) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL14075623 | 0.90 | LGALS8 (0.43) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL14075626 | 0.85 | LGALS8 (0.42) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL472852 | 0.85 | LGALS8 (0.42) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL2629582 | 0.85 | LGALS8 (0.42) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL10077887 | 0.84 | LGALS8 (0.41) | FGF1FGF2VEGFAHPSELGALS8 | |
| SCHEMBL14075624 | 0.81 | CYP2D6 (0.36) | LMNACYP2D6 | |
| SCHEMBL2629586 | 0.81 | CYP2D6 (0.36) | LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412720-B1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | GLYTECH INC (JP) | 2015-10-21 | — | — | EP | disclosed |
| EP-1520858-B1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides | GLYTECH INC (JP) | 2013-11-27 | — | — | EP | disclosed |
| US-8399656-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2412720-A2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | Otsuka Chemical Co., Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-8063202-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-11-22 | — | — | US | disclosed |
| US-7943763-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL HOLDINGS CO., LTD. (JP) | 2011-05-17 | — | — | US | disclosed |
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | GLYTECH, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20050222382-A1 | Process for producing sugar peptide having asparagine sugar chain and the sugar peptide | GLYTECH, INC. (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1520858-A1 | PROCESS FOR PRODUCING SUGAR PEPTIDE HAVING ASPARAGINE SUGAR CHAIN AND THE SUGAR PEPTIDE | OTSUKA CHEMICAL COMPANY, LTD. (JP) | 2005-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | ASNS, BSG, ANPEP | FGF1 2220/4885FGF2 1772/4885VEGFA 1323/4885 |
| US-20050222382-A1 | Process for producing sugar peptide having asparagine sugar chain and the sugar peptide | ASNS, ANPEP, GCG | FGF1 1803/4885FGF2 1511/4885VEGFA 979/4885 |
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | ASNS, ANPEP, B3GNT2 | FGF1 2412/4885FGF2 2059/4885VEGFA 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.